Data integrity within the biopharmaceutical sector in the era of Industry 4.0

Author:

Alosert Haneen1ORCID,Savery James2,Rheaume Jennifer3,Cheeks Matthew4,Turner Richard5,Spencer Christopher4,S. Farid Suzanne1ORCID,Goldrick Stephen1ORCID

Affiliation:

1. The Advanced Centre of Biochemical Engineering Department of Biochemical Engineering University College London London UK

2. Bioprocess Development Data Science & Modelling AstraZeneca Cambridge UK

3. Equipment and Software Validation Development Quality Biologics AstraZeneca Gaithersburg Maryland USA

4. Cell Culture Fermentation Sciences Biopharmaceuticals Development R&D AstraZeneca Cambridge UK

5. Purification Process Sciences Biopharmaceuticals Development R&D AstraZeneca Cambridge UK

Publisher

Wiley

Subject

Molecular Medicine,Applied Microbiology and Biotechnology,General Medicine

Reference29 articles.

1. FDA. (2018 August 10).Warning letter Kyowa Hakko Bio Co. Ltd. U.S. FOOD & DRUG ADMINISTRATION.https://www.fda.gov/inspections‐compliance‐enforcement‐and‐criminal‐investigations/warning‐letters/kyowa‐hakko‐bio‐co‐ltd‐543924‐08102018

2. Industry 4.0: a vision for personalized medicine supply chains?

3. Data science tools and applications on the way to Pharma 4.0

4. FDA. (2018).Data Integrity and Compliance With Drug CGMP Questions and Answers Guidance for Industry(Issue December).https://www.fda.gov/media/119267/download

Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3